articleTop 1% cited
Risks in new drug development: Approval success rates for investigational drugs
Clinical Pharmacology & Therapeutics · 2001 · Vol. 69(5) · pp. 297–307
Joseph A. DiMasi✉(Tufts University)
Abstract
Clinical Pharmacology & Therapeutics (2001) 69 , 297–307; doi: 10.1067/mcp.2001.115446
Pharmaceutical Economics and PolicyHealth Systems, Economic Evaluations, Quality of LifeBiosimilars and Bioanalytical MethodsInvestigational DrugsDrug developmentDrug approvalMedicineDrugPharmacologyIntensive care medicineClinical trialInternal medicine
MeSH terms
Drug IndustryHumansProbabilityResearchTime FactorsUnited StatesDrugs, InvestigationalDatabases, Factual
Citations
455
FWCI
53.20
field-weighted impact
References
22
Percentile
100%
vs. same field & year
Citations per year
Cited by
Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs
Clinical Pharmacology & Therapeutics · 2010 · 839 citations
Clinical development success rates for investigational drugs
Nature Biotechnology · 2014 · 2,462 citations
Related articles
Risks in new drug development: Approval success rates for investigational drugs
Clinical Pharmacology & Therapeutics · 2001 · 455 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.